Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-05-19 @ 6:58 PM
Study NCT ID:
NCT04530994
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2021-10-20
First Post:
2020-08-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)
Sponsor:
Mirum Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Alagille Syndrome | View |